Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    - Revision: v3.4.1 replaces v3.4.0 on the page.
    Difference
    0.0%
    Check dated 2026-02-07T08:27:42.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0). Some labels were removed or changed (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-24T02:52:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a new Revision tag: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:53:27.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across US states and Canadian provinces. Removed the HHS Vulnerability Disclosure notice and updated the revision tag to v3.3.3.
    Difference
    1%
    Check dated 2025-12-19T10:23:43.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The update shows a minor site revision from v3.3.1 to v3.3.2 with no evident changes to the study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T01:35:15.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The Publications section gained a PubMed-listed case report citation and a revision note (v3.3.1), while the previous generic publication description was removed.
    Difference
    0.1%
    Check dated 2025-11-21T01:50:22.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.